Efficacy of duloxetine versus alternative oral therapies: An indirect comparison of randomised clinical trials in chronic low back pain

European Spine Journal

Volumn 22, Issue 9, 2013, Pages 1996-2009

  Cawston, Hélène ^a   Davie, Alison ^b   Paget, Marie Ange ^c   Skljarevski, Vladimir ^c   Happich, Michael ^c  

^a OptumInsight   (France)

^b OPTUM   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Chronic low back pain; Duloxetine; Indirect comparison; Meta analysis

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CYCLOOXYGENASE 2 INHIBITOR; DULOXETINE; ETORICOXIB; GLUCOSAMINE; HYDROMORPHONE; NALTREXONE; OPIATE DERIVATIVE; OXYCODONE; OXYMORPHONE; PARACETAMOL PLUS TRAMADOL; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TAPENTADOL; TRAMADOL;

ALTERNATIVE MEDICINE; ARTICLE; DATA BASE; DRUG DOSE TITRATION; DRUG EFFICACY; HUMAN; INTERMETHOD COMPARISON; LOW BACK PAIN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANALGESICS; CHRONIC PAIN; HUMANS; LOW BACK PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIOPHENES;

EID: 84885314362     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-013-2804-7     Document Type: Article

References (36)

1. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G (2006) Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 15(Suppl 2):S192-S300
2. Birbara CA, Puopolo AD, Munoz DR, Sheldon EA, Mangione A, Bohidar NR, Geba GP (2003) Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability - a randomized, placebo-controlled, 3-month trial. J Pain 4:307-315
3. Buynak R, Shapiro DY, Okamoto A, Van HI, Rauschkolb C, Steup A, Lange B, Lange C, Etropolski M (2010) Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo and active-controlled Phase III study. Expert Opin Pharmacother 11:1787-1804
4. Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, Owens DK (2007) Diagnosis and treatment of low back pain: a joint clinical practice guideline from the american college of physicians and the american pain society. Ann Intern Med 147:478-491
5. Choy E, Marshall D, Gabriel ZL, Mitchell SA, Gylee E, Dakin HA (2011) A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. Semin Arthritis Rheum 41:335-345
6. Deyo RA (1996) Drug therapy for back pain. Which drugs help which patients? Spine 21:2840-2849
7. Dickens CJ (2000) The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain. Psychosomatics 41:2000
8. Eli Lilly and Company (2009) Effect of duloxetine 60 mg once daily versus placebo in patients with chronic low back pain (F1 J-Mc-HMGC). Internal report: 1-983
9. Eli Lilly and Company (2008) Duloxetine versus placebo in the treatment of chronic low back pain (F1 J-MC-HMEO). Internal report: 1-1435
10. Eli Lilly and Company (2008) Effect of duloxetine 60 mg to 120 mg once daily in patients with chronic low back pain (F1 J-MC-HMEN). Internal report: 1-614
11. Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, Clauw DJ (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50:613-623
12. Grabois M (2005) Management of chronic low back pain. Am J Phys Med Rehabil 84:S29-S41
13. Hale M, Khan A, Kutch M, Li S (2010) Once daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain. Curr Med Res Opin 26:1505-1518
14. Hale ME, Ahdieh H, Ma T, Rauck R (2007) Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. J Pain 8:175-184
15. Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, Orlando
16. Higgins JPT, Green S (2009) Cochrane handbook for systematic reviews of interventions. version 5.0.2 [updated September 2009]. The cochrane collaboration
17. Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A (2011) Conducting indirect-treatment comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value Health 14:429-437
18. Hoy D, Brooks P, Blyth F, Buchbinder R (2010) The epidemiology of low back pain. Best Pract Res Clin Rheumatol 24:769-781
19. Katz N, Rauck R, Ahdieh H, Ma T, Gerritsen vdH, Kerwin R, Podolsky G (2007) A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin 23:117-128
20. Machado LA, Kamper SJ, Herbert RD, Maher CG, McAuley JH (2009) Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials. Rheumatology 48:520-527
21. Moore RA, Straube S, Derry S, McQuay HJ (2010) Chronic low back pain analgesic studies - a methodological minefield. Pain 149:431-434
22. Pallay RM, Seger W, Adler JL, Ettlinger RE, Quaidoo EA, Lipetz R, O'Brien K, Mucciola L, Skalky CS, Petruschke RA, Bohidar NR, Geba GP (2004) Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 33:257-266
23. Peloso PM, Fortin L, Beaulieu A, Kamin M, Rosenthal N (2004) Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 31:2454-2463
24. Quilici S, Chancellor J, Lothgren M, Simon D, Said G, Le TK, Garcia-Cebrian A, Monz B (2009) Meta-analysis of duloxetine versus pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurol 9:6
25. Ruoff GE, Rosenthal N, Jordan D, Karim R, Kamin M (2003) Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 25:1123-1141
26. Shekelle PG, Markovich M, Louie R (1995) An epidemiologic study of episodes of back pain care. Spine (Phila Pa 1976) 20:1668-1673
27. Shekelle PG, Markovich M, Louie R (1995) Comparing the costs between provider types of episodes of back pain care. Spine (Phila Pa 1976) 20:221-226
28. Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, Iyengar S, Atkinson JH, Backonja M (2010) Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976) 35:E578-E585
29. Skljarevski V, Ossanna M, Liu-Seifert H, Zhang Q, Chappell A, Iyengar S, Detke M, Backonja M (2009) A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 16:1041-1048
30. Skljarevski V, Zhang S, Desaiah D, Alaka KJ, Palacios S, Miazgowski T, Patrick K (2010) Duloxetine versus placebo in patients with chronic low back pain: a 12 week, fixed-dose, randomized, double-blind trial. J Pain 11:1282-1290
31. Spiegelhalter D, Abrams K, Myles J (2004) Bayesian approaches to clinical trials and health-care evaluation. Statistics in Practice. Wiley, New York
32. Straube S, Derry S, McQuay HJ, Moore RA (2008) Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. Br J Clin Pharmacol 66:266-275
33. Tacconelli E (2010) Systematic reviews: CRD's guidance for undertaking reviews in health care. Lancet Infect Dis 10(4):226
34. Vorsanger GJ, Xiang J, Gana TJ, Pascual ML, Fleming RR (2008) Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag 4:87-97
35. Webster LR, Butera PG, Moran LV, Wu N, Burns LH, Friedmann N (2006) Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain. J Pain 7:937-946
36. Wilkens P, Scheel IB, Grundnes O, Hellum C, Storheim K (2010) Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial. JAMA 304:45-52